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Abstract 
Rare copy number variants associated with increased risk for neurodevelopmental and 
psychiatric disorders (referred to as ND-CNVs) are characterized by heterogeneous 
phenotypes thought to share a considerable degree of overlap. Altered neural integration has 
often been linked to psychopathology and is a candidate marker for potential convergent 
mechanisms through which ND-CNVs modify risk; however, the rarity of ND-CNVs means 
that few studies have assessed their neural correlates. Here, we used 
magnetoencephalography (MEG) to investigate resting-state oscillatory connectivity in a 
cohort of 42 adults with ND-CNVs, including deletions or duplications at 22q11.2, 15q11.2, 
15q13.3, 16p11.2, 17q12, 1q21.1, 3q29, and 2p16.3, and 42 controls. We observed decreased 
connectivity between occipital, temporal and parietal areas in participants with ND-CNVs. 
This pattern was common across genotypes and not exclusively characteristic of 22q11.2 
deletions, which were present in a third of our cohort. Furthermore, a data-driven graph 
theory framework enabled us to successfully distinguish participants with ND-CNVs from 
unaffected controls using differences in node centrality and network segregation. Together, 
our results point to alterations in electrophysiological connectivity as a putative common 
mechanism through which genetic factors confer increased risk for neurodevelopmental and 
psychiatric disorders. 
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Introduction 1 
A number of rare genetic variants occurring through the deletion or duplication of 2 
chromosomal segments are associated with significantly increased risk for a range of 3 
neurodevelopmental disorders (ND), including schizophrenia, autism spectrum disorder 4 
(ASD), and developmental delay 1. Although the underlying mechanisms remain poorly 5 
understood, these copy number variants (referred to hereafter as ND-CNVs) are thought to 6 
increase the risk for psychopathology through alterations in neural structure and function. 7 
Thus, neuroimaging studies in participants with ND-CNVs provide a unique opportunity to 8 
study intermediate phenotypes of mental disorders.  9 
Recent work suggests that CNV-specific phenotypic outcomes are limited, pointing instead to 10 
a large degree of similarity across phenotypes associated with different ND-CNVs 2,3. 11 
Focusing on convergent neural alterations across different genotypes can thus help elucidate 12 
the mechanisms linking ND-CNVs at different loci to a shared psychopathology and increase 13 
in neurodevelopmental risk.  14 
Failures of functional neural integration have long been considered a hallmark of 15 
neurodevelopmental disorders such as schizophrenia 4,5. In recent years, evidence of 16 
disrupted connectivity has also emerged in ASD populations 6,7 and has been shown to 17 
transcend diagnostic boundaries 8. ND-CNVs are thought to increase disorder risk by acting 18 
on large-scale neural integration through molecular and cellular mechanisms 9. Studying 19 
functional network alterations in participants with ND-CNVs could thus help establish their 20 
reliability as biomarkers of neurodevelopmental risk. Synchronous oscillatory activity 21 
thought to support communication between brain areas is of particular interest as a potential 22 
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biomarker of neurodevelopmental risk, and can be measured at rest using electro- and 23 
magneto-encephalography (EEG/MEG).  24 
However, the rarity of ND-CNVs means that evidence of their functional connectivity 25 
correlates is scarce. Of the genetic imaging studies conducted so far, most have focused on 26 
the 22q11.2 deletion syndrome. This deletion is associated with a number of physical 27 
phenotype manifestations as well as high risk for psychopathology 10–13. The presence of a 28 
22q11.2 deletion has been linked to alterations in brain structure and function 14–17, including 29 
disrupted structural connectivity 18,19. Although fewer studies have investigated functional 30 
connectivity, they report similarly disrupted networks using functional MRI 20–22 and EEG 23. 31 
Despite emerging evidence of white matter alterations associated with other ND-CNVs 24–26, 32 
very few studies have investigated their functional correlates. Recent electrophysiological 33 
research reported increased beta-band activity in participants with 15q11.2-q13.1 duplications 34 
27,28 and 16p11.2 deletions 29, as well as delayed evoked responses in the latter 24,30. Based on 35 
current evidence it is difficult to assess the extent of functional connectivity alterations, 36 
especially for rarer ND-CNVs. 37 
To address this, we investigated oscillatory connectivity measured with MEG in participants 38 
with ND-CNVs at nine different loci. Given the common phenotypic outcomes associated 39 
with ND-CNVs 2, this approach can identify convergent endophenotypes of potentially higher 40 
clinical relevance. Because a third of our cohort had 22q11.2 deletions, we also investigated 41 
alterations in connectivity separately in this subgroup and in the group of participants with 42 
other ND-CNVs. This allowed us to assess the specificity of the effects, especially 43 
considering previous findings of widespread neural alterations associated with 22q11.2 44 
deletions.  45 
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In both subgroups, we found evidence of disrupted alpha and beta-band oscillatory 46 
connectivity in posterior brain regions. Furthermore, using graph theory measures of network 47 
topology and information transfer, we were able to identify participants with ND-CNVs 48 
based on their individual connectivity maps. The two approaches highlighted common 49 
patterns of dysconnectivity in participants with ND-CNVs, as well as specific network 50 
features that might be linked to CNV pathogenicity. 51 
Materials and Methods 52 
Participants 53 
MEG data were acquired in 42 adults with ND-CNVs targeted for their high penetrance for 54 
neurodevelopmental disorders (22 female; mean age 38.5±12.5 years; range 19-76). ND-55 
CNVs at nine different loci were represented in the cohort, with 14 (33%) participants 56 
carrying 22q11.2 deletions (Table 1).  57 
Recruitment was performed through NHS genetics clinics and relevant support groups within 58 
the UK. Written consent was obtained in accordance with The Code of Ethics of the World 59 
Medical Association (Declaration of Helsinki), and all procedures were approved by the 60 
South East Wales Research Ethics Committee. Informed consent was obtained from all 61 
subjects. 62 
All participants with ND-CNVs were assessed using the Psychiatric Assessment Schedule for 63 
Adults with Developmental Disability (PAS-ADD; Moss et al., 1997). 24 were also assessed 64 
using the Structured Interview for Prodromal Symptoms (SIPS; Miller et al., 2003), and 26 65 
using the Structured Clinical Interview for DSM (SCID II; First and Gibbon, 2004). 66 
Diagnoses were assigned by research psychologists and verified by an adult psychiatrist using 67 
the Diagnostic and Statistical Manual for Mental Disorders, 4th and 5th Editions. Of the 42 68 
participants, 34 had at least one diagnosis; 22 had anxiety disorders, 15 had mood disorders, 69 
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and 15 had neurodevelopmental disorders (including 6 with intellectual disability and 6 with 70 
autism spectrum disorders). Five participants exhibited full or attenuated psychotic 71 
symptoms, of whom four met the criteria for a psychotic disorder, with two schizophrenia 72 
diagnoses in the 22q11.2 deletion group. There was no significant difference in number of 73 
diagnoses between the 22q11.2 deletion group and the other ND-CNV group (t(33.7) = 0.14, 74 
P = 0.89). 75 
IQ tests were administered using the Wechsler Adult Intelligence Scale (WAIS-III). We 76 
report Verbal IQ (VIQ), Performance IQ (PIQ) and Full Scale IQ scores (FSIQ). There was 77 
no significant difference in IQ between the 22q11.2 deletion group and the other ND-CNV 78 
group (t(22.7-25.1) < 0.57, P > 0.58). 79 
In the ND-CNV group, 62% of participants were taking medication for physical, neurological 80 
or mood disorders (e.g. high blood pressure, asthma, pain/migraine, depression/anxiety), with 81 
the most common medications including gabapentin, co-codamol (combination of codeine 82 
and paracetamol), and fluoxetine (N = 3). Given the high variability of medications, their 83 
effects could not be systematically investigated; however, their impact was alleviated in 84 
MEG analysis by tests of generalizibility (e.g. resampling). 85 
Controls were selected among resting-state datasets acquired at CUBRIC as part of the “100 86 
Brains”’ and “UK MEG Partnership” projects. These cohorts included healthy participants 87 
with no history of neurological or neuropsychiatric disorders, and 42 controls were chosen to 88 
match the gender and age of the ND-CNV carriers as closely as possible (22 female; mean 89 
age 33.3±9.6 years; range 22-71). These measurements were acquired under protocols 90 
approved by the Cardiff University School of Psychology Ethics Committee, and informed 91 
consent was obtained from all participants. 92 
7 
 
Since a third of the ND-CNV cohort consisted of participants with 22q11.2 deletions, we 93 
assessed the impact of this subgroup by repeating all analyses on (1) participants with other 94 
ND-CNVs (except 22q11.2 deletions) and their matched controls (N = 56), and (2) 95 
participants with 22q11.2 deletions and their matched controls (N = 28).  96 
Genotyping 97 
Participants with ND-CNVs were genotyped using the Illumina HumanCoreExome whole 98 
genome SNP array, which contained an additional 27 000 genetic variants at loci previously 99 
linked to neurodevelopmental disorders, including CNVs. The raw intensity data was 100 
processed using Illumina Genome Studio software (version 2011.1). PennCNV (version 101 
1.0.3) was used to perform CNV calling in order to confirm the presence of the ND-CNV in 102 
each case sample, with each CNV being required to span a minimum of 10 informative SNPs 103 
and to be at least 10 kb in length. CNV coordinates were specified according to genome 104 
version hg19, and the boundaries of each CNV were confirmed by manually inspecting the 105 
Log R ratio and B allele frequency plots at each of the genomic regions of interest (Table 1). 106 
Genetic information was not available for control participants; given the rarity of these 107 
genotypes in the general population, they were assumed to carry no ND-CNVs.  108 
Data collection 109 
Five-minute resting-state MEG recordings were made using a 275-channel CTF radial 110 
gradiometer system (CTF, Vancouver, Canada) at a sampling rate of 1200 Hz. Three of the 111 
sensors were turned off due to excessive noise, and 29 reference channels were recorded to 112 
improve noise cancellation34. During the recordings, participants were seated upright and 113 
fixated their eyes on a red fixation point presented centrally on either a CRT monitor or LCD 114 
projector. Three electromagnetic coils were placed at fiducial locations (nasion and pre-115 
auricular) for head localization. 116 
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To aid in source localization, structural T1-weighted MRI scans were also acquired using a 117 
3T General Electric or Siemens MRI scanner with a 1 mm isotropic FSPGR/MPRAGE pulse 118 
sequence.  119 
Data analysis 120 
Pre-processing 121 
To remove muscle artifacts, a semi-automatic procedure was implemented using the 122 
FieldTrip toolbox 35 and MATLAB R2015a. Sensor time-series were bandpass-filtered 123 
between 110 and 140 Hz and z-transformed; segments exceeding a participant-specific z-124 
score threshold were removed. Next, eye movement and cardiac artifacts were projected out 125 
of the data using Independent Component Analysis (ICA). Noisy channels exhibiting high 126 
variance were also removed from the data where necessary. There was no significant 127 
difference in recording duration after artifact rejection between the ND-CNV and control 128 
groups (t(81.8) = 1.61, P = 0.11, mean duration 255.88±29.31 s and 245.33±30.86 s 129 
respectively). 130 
Head motion was monitored continuously in 18/42 ND-CNV datasets and 40/42 control 131 
datasets, and head localization was performed at the start and end of the recording in the 132 
remaining datasets. There was no significant difference between the ND-CNV and control 133 
groups in maximum head coil displacement between the beginning and end of the recording 134 
(t(79.8) = 0.85, P = 0.39, mean displacement 2.07±3.62 mm and 2.7±3.06 mm respectively). 135 
In datasets with continuous head localization, the maximum distance of the head coils from 136 
their average position across the entire recording did not significantly differ between groups 137 
(t(39.4) = 1.44, P = 0.16, mean distance 4.74±3.5 mm and 3.21±4.2 mm respectively).  138 
Prior to source localization, coregistration was performed by manually marking head coil 139 
locations on each participant's MRI using FieldTrip. The data were downsampled to 600 Hz 140 
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and bandpass-filtered in six different frequency bands: delta (2-4 Hz), theta (4-8 Hz), alpha 141 
(8-13 Hz), beta (13-30 Hz), low gamma (40-60 Hz), and high gamma (60-90 Hz).   142 
Estimating functional connectivity 143 
To assess group differences in resting-state connectivity (Figure 1), we focused on amplitude-144 
amplitude coupling of source-localized oscillatory signals 36. Continuous data in each of the 145 
six frequency bands were projected into source space using a Linearly Constrained Minimum 146 
Variance (LCMV) beamformer. Sources were reconstructed on a 6 mm template grid warped 147 
to each participant's MRI, using a multiple local-spheres forward model 37. To alleviate the 148 
depth bias, beamformer weights were normalized by their vector norm 38. 149 
Next, 90 nodes corresponding to cortical regions of interest (ROI) in the Automated 150 
Anatomical Labelling (AAL) atlas 39 were identified by performing a frequency analysis on 151 
all sources within each ROI and selecting the source with the largest temporal standard 152 
deviation. Continuous virtual sensor timecourses corresponding to the 90 nodes were then 153 
reconstructed and bandpass-filtered into the frequency bands of interest. 154 
To avoid spurious correlations, the node time-series were orthogonalized using a multivariate 155 
symmetric orthogonalization approach 40. A Hilbert transform was used to calculate 156 
oscillatory amplitude envelopes, which were then despiked using a median filter, 157 
downsampled to 1 Hz, and trimmed to avoid filter and edge effects. To obtain connectivity 158 
matrices, pairwise correlations were calculated between the 90 Hilbert envelopes. Next, a 159 
Fisher transform was applied to obtain z-scores with zero mean and unit variance across 160 
connections in each participant’s map. This procedure corrected for possible systematic 161 
differences across participants, for example due to differences in data quality 41.  162 
Intracranial volume (ICV), quantified as the number of 1-mm isotropic voxels inside the 163 
brain, was smaller in the ND-CNV group than the control group (t(65.5) = -2.19, P = 0.03), in 164 
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line with some previous reports 42–44. The potential impact of this difference on the MEG 165 
results was alleviated through the source localization procedure and the z-scoring of the 166 
connectivity matrices.  167 
In addition to the six frequency bands listed above, a combined measure of connectivity was 168 
obtained by calculating the vector-sum of connectivity matrices across all frequency bands 45.  169 
Group differences in resting-state connectivity 170 
To reduce the impact of noise, a conservative ranking procedure 45 was used to threshold the 171 
connectivity maps for the purposes of between-group comparisons. This consisted of 172 
calculating the rank of each connection in participant-level connectivity matrices and 173 
averaging the resulting rank map across participants in each group. Only the top 20% edges 174 
in the average rank map were considered "valid" and selected for further analysis. To ensure 175 
that large differences in signal across cohorts were not discarded by this procedure, the rank-176 
thresholding procedure was performed separately in each cohort, and connections determined 177 
as "valid" in either cohort were included in further analysis.  178 
We report differences between groups using three statistical thresholds. First, Welch’s t-tests 179 
were conducted at each valid edge, and initial patterns were identified using an uncorrected α 180 
= 0.05. Second, correction for multiple comparisons was applied using a randomization 181 
procedure with 10000 sign-shuffling iterations and maximal statistic thresholding (omnibus α 182 
= 0.05; Nichols and Holmes, 2001).  183 
Third, the robustness of cohort differences was evaluated through a resampling procedure. 184 
Increases and decreases in connectivity between groups were tabulated using random samples 185 
of half of each group. This was repeated across 10000 iterations, and edges showing a 186 
consistent effect direction across at least 95% of iterations were considered robust.  187 
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Although few edges survived the conservative omnibus correction across individual 188 
connections, we based our conclusions on the resampling analysis, which converged with the 189 
uncorrected t-test results and pointed to robust patterns of differences in connectivity. 190 
Furthermore, we performed a decoding analysis using graph theory metrics to assess the 191 
discriminating information present at the network level (see below).  192 
To control for potential confounds (for example, resulting from imperfect age matching 193 
between the ND-CNV and control groups), an additional multiple regression analysis was 194 
performed. Combined-frequency connectivity matrices were entered as response variables 195 
with a categorical predictor (ND-CNV presence) and three covariates (age, gender, and ICV). 196 
A resampling procedure as described above was performed to assess the robustness of 197 
between-group differences. The sign of the regression slope associated with the main 198 
predictor was tabulated across 1000 split-half cohort randomizations. Edges showing 199 
consistent effects across 95% of iterations were considered robust.  200 
This is an exploratory study with a limited sample size due to the rarity of ND-CNVs. 201 
Although we are not aware of similar MEG investigations, an EEG study in participants with 202 
22q11.2 DS 23 found resting-state connectivity effect sizes ranging from moderate to large. 203 
Our sample size can detect a large effect (Cohen’s d = 0.8) with 95% power and a moderate 204 
effect (d = 0.5) with 62% power according to a post-hoc power analysis. 205 
Individual networks: identifying participants with ND-CNVs using graph theory 206 
Next, a data-driven graph theory approach was used to assess whether participants with ND-207 
CNVs could be distinguished from unaffected controls using functional connectivity features. 208 
To this aim, the cohort was divided into training and test sets using an iterated cross-209 
validation procedure.  210 
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This analysis focused on individual networks by selecting the top 20% of connections in each 211 
participant’s normalized connectivity map as the basis for undirected graphs. This approach 212 
avoided bias by ensuring the independence of training and test sets, while at the same time 213 
allowing us to detect any informative differences in connection strength. Networks were then 214 
characterized using six nodal graph theory metrics. These included three measures of node 215 
connectedness: degree (the number of connections linking each node to other nodes); 216 
betweenness centrality (the fraction of shortest paths between nodes containing a given 217 
node); and eccentricity (the maximal shortest path from a node to any other node). Global 218 
efficiency (the average inverse shortest path between a node and all others) was evaluated as a 219 
measure of network integration. Finally, two metrics captured network modularity: local 220 
efficiency (the average inverse shortest path between a node and its neighbours) and 221 
clustering coefficient (the fraction of connected node triplets around a node). All metrics with 222 
the exception of node degrees were weighted by the inverse of the normalized connectivity 223 
matrices; in other words, stronger amplitude-amplitude coupling was taken to reflect shorter 224 
paths between nodes. Graph theory analyses were performed using the graph and network 225 
algorithms in MATLAB R2019a and the Brain Connectivity Toolbox 47. 226 
To discriminate between groups, a linear support vector machine (SVM) classifier 48 was 227 
trained on each of the node metrics. Additionally, a pooled feature vector was created by 228 
combining the six metrics to maximize the amount of complementary information input to 229 
the classifier. This approach makes use of information across all nodes while avoiding the 230 
need for multiple testing. 231 
Classification was performed between the ND-CNV and control groups, as well as between 232 
the two ND-CNV subgroups (22q11.2 deletions and other ND-CNVs) and their matched 233 
controls. To avoid overfitting, model performance was evaluated using 100 iterations of 234 
stratified five-fold cross-validation. This entailed iteratively leaving out a fifth of the data for 235 
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testing and training the model on the remaining data, whilst ensuring balanced group 236 
representation in each fold. Performance was quantified using accuracy (proportion correctly 237 
classified observations), sensitivity (true positive rate) and specificity (true negative rate) in 238 
order to highlight any asymmetries in ND-CNV and control identification. Furthermore, 239 
significance was assessed by shuffling the true labels 5000 times and recomputing classifier 240 
accuracy to estimate the empirical chance level and calculate a one-tailed p-value 46.  241 
Code availability 242 
The resting-state connectivity analysis was performed using Matlab in-house scripts and 243 
results were plotted using the SourceMesh toolbox 244 
(https://github.com/alexandershaw4/SourceMesh). The graph theory analysis was performed 245 
using using the graph and network algorithms in MATLAB R2019a and the Brain 246 
Connectivity Toolbox 47. Decoding analyses were performed using in-house Matlab scripts 247 
(https://github.com/dianadima/mvpa-for-meg) and the LibLinear library 49. All custom code 248 
is available upon request. 249 
Results 250 
Connectivity alterations associated with ND-CNVs 251 
The analysis of group differences in oscillatory connectivity revealed the largest number of 252 
valid connections (exceeding a rank of 0.8 in group average maps) in the alpha and beta 253 
bands (Figure 2). The uncorrected t-test showed a pattern of decreases in oscillatory 254 
connectivity between posterior, parietal and temporal nodes in the ND-CNV group, with the 255 
exception of a few right-hemisphere edges. More extensive cohort effects were detected 256 
using the combined frequency maps (61 edges exceeded the uncorrected threshold, compared 257 
to 1, 28 and 42 in the theta, alpha and beta bands). These patterns were robust to random sub-258 
sampling of the cohort, suggesting that they were not driven by individual subjects. Most 259 
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connections did not survive omnibus correction for multiple comparisons at the individual 260 
edge level, with the exception of a small number of left-hemisphere connections, including 261 
the precuneus, early visual cortex, and parietal regions. 262 
Importantly, a similar pattern of hypoconnectivity was observed even after excluding 263 
participants with 22q11.2 deletions and their matched controls (Figure 2B-C). Both ND-CNV 264 
subgroups showed decreased posterior connectivity (Figure 3; 18 connections decreased in 265 
both groups), indicating that the overall pattern was not driven by the 22q11.2 deletion group.  266 
This pattern occurred despite higher heterogeneity in the mixed ND-CNV group 267 
(Supplementary Figure 1) and might thus reflect convergent alterations across genotypes. On 268 
the other hand, participants with 22q11.2 deletions exhibited more right-hemisphere 269 
hyperconnectivity compared to controls. These effects spanned the precuneus and parietal 270 
cortex, as well as frontal regions, suggesting some overlap with the default mode network 271 
(DMN).  272 
To ensure that these differences were not affected by potential confounds, the cohort 273 
resampling tests on combined frequency maps were repeated as a multiple linear regression 274 
with age, gender and ICV as covariates. This analysis revealed fewer connections (65 275 
compared to the original 92 in the whole cohort analysis), but largely similar patterns of 276 
dysconnectivity (Figure 3B). 277 
Furthermore, although IQ scores could not be included in this analysis because they were not 278 
available for the control group, IQ scores in the ND-CNV group significantly correlated with 279 
connectivity strength at only four edges (Supplementary Figure 2). 280 
Network features as predictors of ND-CNV status  281 
A graph theory framework was employed to identify participants with ND-CNVs from their 282 
functional networks based on combined frequency maps. This approach has the advantage of 283 
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reducing dimensionality and complements the edge-focused group testing approach described 284 
above. Despite methodological differences between the two analyses, a visualization of the 285 
nodal graph theory features shows overlap with the nodes highlighted in the group analysis 286 
(Supplementary Figures 3-6). 287 
Graph theory metrics were successful predictors of ND-CNV participants relative to 288 
unaffected controls. The best prediction accuracy was achieved by combining the 6 node 289 
features (Supplementary Table 1; Figure 4A; maximum accuracy 71%±3.44, P=0.0002). 290 
However, participants with 22q11.2 deletions were more consistently correctly classified than 291 
those with other ND-CNVs (Figure 4B).  292 
This was confirmed by subgroup classification analyses, which also pointed to subgroup 293 
differences. When excluding participants with 22q11.2 deletions, the best decoding 294 
accuracies were achieved using node eccentricities (65.62%±3.91, P=0.0016), node degrees, 295 
and a joint feature model. On the other hand, all node features were successful in 296 
discriminating participants with 22q11.2 deletions from their matched controls, with the best 297 
performance obtained using the clustering coefficient (87.61%±4.95, P=0.0002). 298 
Furthermore, removing the connectivity map thresholding step from this analysis did not 299 
significantly affect the results. This suggests that successful classification is not exclusively 300 
driven by differences in edge selection (Supplementary Figure 7). 301 
These results point to commonalities in network features (such as decreased centrality) that 302 
allow for the successful classification of participants with ND-CNVs across distinct 303 
genotypes. On the other hand, the features are specific enough to allow successful 304 
discrimination between participants with 22q11.2 deletions and other ND-CNVs 305 
(Supplementary Table 1).  306 
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Given the higher overall burden of 22q11.2 deletions in neurodevelopmental disorders 1, this 307 
suggests that increased neurodevelopmental risk may be associated with more salient 308 
alterations in network function and may underpin specific genotype effects.  309 
Discussion 310 
To our knowledge, the present study provides the first insight into oscillatory connectivity 311 
alterations in people with rare ND-CNVs. Using both an established group analysis pipeline 312 
and a data-driven graph theory framework, we uncovered a pattern of functional 313 
dysconnectivity affecting posterior regions in participants with ND-CNVs. Although 314 
individual connection effect sizes were generally low, these patterns were robust to effects of 315 
age, gender, and intracranial volume, and emerged despite a conservative thresholding 316 
approach restricted to the most reproducible connections. These patterns also allowed for the 317 
successful classification of participants with ND-CNVs using graph theory metrics. 318 
Effects originated in the alpha and beta frequency bands, which are thought to underpin long-319 
range communication between brain areas 50. Connections linking parietal, temporal, and 320 
occipital areas were most consistently affected in both the 22q11.2 deletion group and the 321 
other ND-CNV group. Similar patterns have been previously reported in schizophrenia 322 
patients 51, including alpha-band parietal hypoconnectivity in first-episode schizophrenia 52. 323 
Furthermore, posterior structural network alterations have been identified as an early marker 324 
of ASD 53, suggesting a link between such alterations and increased neurodevelopmental risk. 325 
Similar connectivity changes in the visual processing system and the default mode network 326 
have been shown in people with 22q11.2 deletions using structural and functional MRI 54–56. 327 
Here, we found that these effects are not restricted to the 22q11.2 deletion group, suggesting 328 
that long-range connectivity could act as a common marker across genetic variants. Although 329 
non-invasive measurements cannot provide direct mechanistic insight, this is consistent with 330 
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potential alterations in excitatory-inhibitory balance 57,58 as a mechanism for pleiotropic 331 
genetic effects underlying neurodevelopmental disorders 59–61. This is thought to occur 332 
through increased excitation or disinhibition caused by gene haploinsufficiency and mediated 333 
by impaired GABA and NMDA receptor function 62–64. 334 
Despite sample size limitations, differences between the two subgroups also point to effects 335 
specific to the highly penetrant 22q11.2 deletions. Hypoconnectivity was more extensive in 336 
people with other ND-CNVs, while the 22q11.2 deletion group exhibited more focused 337 
patterns; these were robust to cohort resampling, suggesting that they are unlikely to be 338 
driven by individual cases. These differences were reflected in the graph theory analysis. 339 
Although all network features were altered in the 22q11.2 deletion group, their increased 340 
modularity was particularly discriminative, in line with previous reports of increased 341 
structural network segregation in people with 22q11.2 deletions 18,22,65. For other ND-CNVs, 342 
the only predictive features were centrality measures (specifically the node eccentricity and 343 
degree), reflecting hypoconnectivity in the ND-CNV cohort. Between and within-group 344 
classification results (Supplementary Table 1) highlight the ability of graph theory metrics to 345 
capture both convergent and specific network alterations, which could help elucidate the link 346 
between CNV pathogenicity and neural system function.  347 
We alleviated concerns of potential systematic between-group differences unrelated to 348 
genotype by using conservative approaches (e.g. rejecting weaker connections that may 349 
introduce noise) and resampling procedures. Despite generally low effect sizes which did not 350 
survive an omnibus threshold across individual connections, we base our conclusions on the 351 
robustness of the connectivity patterns and their convergence across analyses. Although head 352 
motion did not appear to differ between groups, this was not continuously measured in all 353 
participants and so we could only partially rule out its effects.  354 
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Although the present study was able to evaluate ND-CNV effects independently of the 355 
contribution of highly penetrant 22q11.2 deletions, the limited sample size remains a concern 356 
common in CNV imaging research. The high genotype variability within the cohort makes 357 
the specificity of these effects difficult to assess, particularly with regard to differences 358 
between the 22q11.2 deletion group and other ND-CNVs. Variability within the 359 
heterogeneous ND-CNV group was higher than within the 22q11.2 deletion group 360 
(Supplementary Figure 1), suggesting that our focus on convergent alterations may obscure 361 
specific effects. However, the fact that we see differences robust to resampling in this group, 362 
despite its heterogeneity, points to common connectivity alterations across distinct genotypes. 363 
Studies recruiting larger samples of participants with ND-CNVs, for example through large 364 
multi-site collaborations, are necessary to evaluate the generalizability of connectivity 365 
patterns and graph theory metrics as “fingerprints” associated with ND-CNV status.  366 
In summary, the present study assessed oscillatory long-range connectivity as a potential 367 
marker of pathogenic genetic effects across a range of rare ND-CNVs. Occipital, parietal and 368 
temporal brain areas were characterized by consistent hypoconnectivity across genotypes, 369 
which was not exclusively driven by the presence of a large number of participants with 370 
highly-penetrant 22q11.2 deletions. Functional networks in the ND-CNV group exhibited 371 
decreased node centrality and alterations in network efficiency and structure. Furthermore, 372 
features specific to highly penetrant variants were present alongside convergent network 373 
alterations and enabled successful ND-CNV classification. These results are consistent with a 374 
common mechanism for genetic risk, based on an altered balance between excitatory and 375 
inhibitory synaptic processes and leading to network dysfunction. We propose that these 376 
functional connectivity alterations are an intermediate phenotype on the pathway from 377 
synaptic molecular changes to disruption of cognitive function and psychotic illness. 378 
 379 
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 542 
Table 1 543 
CNV and critical 
region (hg19) 
Total 
N 
N 
female 
Age 
(mean±SD) 
N diag 
(mean±SD) 
VIQ 
(mean±SD) 
PIQ 
(mean±SD) 
FSIQ 
(mean±SD) 
All CNV 42 22 38.53±12.55 2.93±2.54 88.72±18.84 96.63±14.63 91.24±17.15 
22q11.2del 
chr22:19,037,332-
21,466,726 
14 9 38.97±16.43 3±2.07 86.28±21.23 95.28±15.6 89.93±17.88 
22q11.2dup 
chr22:19,037,332-
21,466,726 
4 
13 38.32±10.44 2.89±2.78 90±17.77 97.33±14.36 91.89±17.08 17q12dup 
chr17:34,815,904-
36,217,432 
2 
16p11.2del 1 
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chr16:29,650,840-
30,200,773 
16p11.2dup (distal) 
chr16:28,823,196-
29,046,783 
1 
15q13.1-13.3del (BP4-
5) 
chr15:31,080,645-
32,462,776 
2 
15q13.1-13.3dup (BP4-
5) 
chr15:31,080,645-
32,462,776 
1 
15q11.2del (BP1-2) 
chr15:22,805,313-
23,094,530 
7 
15q11.2dup(BP1-2) 
chr15:22,805,313-
23,094,530 
1 
15q11.2q12dup(BP2-3; 
PWS/AS) 
chr15:22,805,313-
28390339 
1 
3q29del 
chr3:195,720,167-
197,354,826 
1 
2p16.3del (NRXN1) 
chr2:50145643-
51259674 
1 
1q21.1del 
chr1:146,527,987-
147,394,444 
5 
1q21.1dup 
chr1:146,527,987-
147,394,444 
1 
Controls 42 22 33.35±9.58 - - - - 
Figure and table legends 
 544 
Table 1. Participant information (ND-CNV status, demographic information, number of psychiatric 545 
diagnoses, and IQ). Note that the 22q11.2 deletion group included two atypical deletions and one 546 
adjacent deletion. 547 
 548 
Figure 1. Overview of the analysis pipeline. Resting-state MEG data were preprocessed, filtered into 549 
six frequency bands, and projected into source space. Hilbert envelopes were calculated at 90 AAL-550 
atlas-based virtual sensor locations, and correlated to obtain functional connectivity matrices. These 551 
were z-scored and rank-thresholded at the group level for between-group analyses, and at the subject 552 
level for data-driven prediction of ND-CNV status using graph theory.  553 
 554 
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Figure 2. A. Differences in resting-state connectivity (amplitude correlations) between participants 555 
with ND-CNVs and controls. Connections are shown in blue if they are decreased in the ND-CNV 556 
group relative to controls, and in red if they are increased in the ND-CNV group relative to controls. 557 
The rows show (top to bottom): valid connections after mean-rank thresholding in each frequency 558 
band; uncorrected (P<0.05) differences between groups; multiple comparison-corrected (omnibus 559 
P<0.05) differences between groups; and connections showing consistent increases/decreases in 95% 560 
of cohort resampling iterations. B. As in A, for subgroups excluding participants with 22q11.2 561 
deletions and their matched controls (left) or including only participants with 22q11.2 deletions and 562 
their matched controls (right). To facilitate comparison, “valid” connections were the same as in A. 563 
Only frequency bands with surviving “valid” connections are shown. C. Nodes displayed in the 564 
circular plots, labelled and colour-coded by region. Connections shown are the result of the 565 
conjunction analysis between the 22q11.2 deletion group and the other ND-CNV group (also see 566 
Figure 3: blue connections are decreased in both groups; red connections have opposing signs). 567 
 568 
Figure 3. Differences in connectivity are not driven by age, gender, and intracranial volume. 569 
Connections meeting the 95% confidence criterion in the cohort resampling test are displayed for all 570 
group tests (first three columns). Connections are shown in blue if they are decreased in the ND-CNV 571 
group relative to controls, and in red if they are increased in the ND-CNV group relative to controls. 572 
The last column shows supra-threshold connections in both the 22q11.2 deletion group and the other 573 
ND-CNV group; here, connections are shown in blue if they are decreased in both groups, and in red 574 
if they have opposite signs. Line width increases with effect robustness. A. Connections exhibiting 575 
robust differences based on the cohort resampling test of combined frequency matrices, plotted on the 576 
template brain. B. As in A, after including age, gender and intracranial volume as covariates in a 577 
multiple linear regression with “ND-CNV presence” as a main categorical predictor. 578 
 579 
Figure 4. Classifying participants with ND-CNVs and unaffected controls from individual MEG 580 
functional networks using graph theory. A: Classification performance on the three groups, using 581 
28 
 
different metrics to characterize the networks (eccentricity, degree, betweenness centrality, global and 582 
local efficiency, clustering coefficient, and a pooled model combining all features). Above-chance 583 
accuracies (permutation testing) are marked with 1, 2, and 3 dots respectively for p<0.05,  p<0.01, and 584 
p<0.001. B. How well are different ND-CNVs classified? The plot shows the mean predicted label for 585 
each of the 42 participants with ND-CNVs across 100 cross-validation iterations using pooled node 586 
features. Participants with 22q11.2 deletions are most consistently correctly identified. Two 587 
participants with schizophrenia diagnoses are marked with “S”. All error bars are ±SD. 588 




